JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.63B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 3 |
JPMorgan BetaBuilders International Equity ETF
BBIN
|
+$1.55B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$884M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.8B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.77B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$884M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$880M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$834M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.09% |
| 2 | Technology | 16.19% |
| 3 | Financials | 10.76% |
| 4 | Healthcare | 10.54% |
| 5 | Consumer Discretionary | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
VRT.WS
3026
DELISTED
Vertiv Holdings Co Warrants, each whole warrant exercisable for one share of Class A Common Stock at
VRT.WS
| – | – |
0
| – | – |
2020 Q1
1 quarter
|
|
|
DX
3027
Dynex Capital
DX
$2.69B
| $1.83M | ﹤0.01% |
128,090
+4,566
| +4% | +$61.1K |
2016 Q4
14 quarters
|
|
|
TVRD
3028
Tvardi Therapeutics
TVRD
$14.4M
| $1.83M | ﹤0.01% |
2,970
-302
| -9% | -$167K |
2014 Q1
25 quarters
|
|
|
LL
3029
DELISTED
LL Flooring Holdings, Inc.
LL
| $1.83M | ﹤0.01% |
131,859
+121,753
| +1,205% | +$1.03M |
2015 Q4
18 quarters
|
|
|
DESP
3030
DELISTED
Despegar.com
DESP
| $1.83M | ﹤0.01% |
254,488
+185,145
| +267% | +$1.29M |
2020 Q1
1 quarter
|
|
3031
CALL
Allogene Therapeutics
ALLO
$504M
| $1.82M | ﹤0.01% |
+42,600
| New | +$1.54M |
2020 Q2
0 quarters
|
|
3032
PetMed Express
PETS
$28.4M
| $1.82M | ﹤0.01% |
51,107
-31,995
| -39% | -$1.11M |
2015 Q4
18 quarters
|
|
3033
Cal-Maine
CALM
$2.96B
| $1.82M | ﹤0.01% |
40,876
-1,353
| -3% | -$57.6K |
2013 Q2
28 quarters
|
|
3034
Dorchester Minerals
DMLP
$1.43B
| $1.81M | ﹤0.01% |
141,922
-17,914
| -11% | -$204K |
2013 Q2
28 quarters
|
|
|
CLVS
3035
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.81M | ﹤0.01% |
268,177
-64,794
| -19% | -$491K |
2013 Q2
28 quarters
|
|
|
CMD
3036
DELISTED
Cantel Medical Corporation
CMD
| $1.81M | ﹤0.01% |
40,917
-15,127
| -27% | -$564K |
2015 Q4
18 quarters
|
|
|
MTSC
3037
DELISTED
MTS Systems Corp
MTSC
| $1.8M | ﹤0.01% |
102,565
+76,403
| +292% | +$1.41M |
2013 Q2
28 quarters
|
|
3038
iShares Core S&P Total US Stock Market ETF
ITOT
$98.1B
| $1.8M | ﹤0.01% |
25,943
-3,183
| -11% | -$208K |
2014 Q4
22 quarters
|
|
3039
Enerpac Tool Group
EPAC
$1.83B
| $1.8M | ﹤0.01% |
102,313
+66,463
| +185% | +$1.12M |
2015 Q4
18 quarters
|
|
|
RESI
3040
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $1.8M | ﹤0.01% |
207,028
-259
| -0.1% | -$2.37K |
2016 Q4
14 quarters
|
|
3041
Kontoor Brands
KTB
$3.6B
| $1.79M | ﹤0.01% |
100,409
+35,811
| +55% | +$638K |
2019 Q2
4 quarters
|
|
3042
Brookfield Infrastructure Partners
BIP
$17.2B
| $1.79M | ﹤0.01% |
65,133
+51,217
| +368% | +$1.37M |
2015 Q3
19 quarters
|
|
3043
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.7B
| $1.78M | ﹤0.01% |
10,812
+2,529
| +31% | +$382K |
2015 Q4
18 quarters
|
|
|
CVSA
3044
Covista Inc
CVSA
$4.31B
| $1.78M | ﹤0.01% |
57,259
+864
| +2% | +$27K |
2013 Q2
28 quarters
|
|
3045
iShares MSCI Malaysia ETF
EWM
$285M
| $1.77M | ﹤0.01% |
70,181
-3,775
| -5% | -$92.2K |
2013 Q2
28 quarters
|
|
3046
HEICO Corp
HEI
$42.4B
| $1.77M | ﹤0.01% |
17,748
-4,572
| -20% | -$422K |
2013 Q2
28 quarters
|
|
3047
CALL
Xerox
XRX
$385M
| $1.77M | ﹤0.01% |
+115,700
| New | +$2M |
2020 Q2
0 quarters
|
|
|
DFNS.U
3048
DELISTED
LGL Systems Acquisition Corp. Units
DFNS.U
| $1.77M | ﹤0.01% |
172,500
+171,500
| +17,150% | +$1.72M |
2020 Q1
1 quarter
|
|
3049
CALL
Synchrony
SYF
$23.5B
| $1.77M | ﹤0.01% |
+79,700
| New | +$1.55M |
2020 Q2
0 quarters
|
|
3050
Pathward Financial
CASH
$1.52B
| $1.76M | ﹤0.01% |
96,900
+14,602
| +18% | +$256K |
2015 Q2
20 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2020 Portfolio in Review
As of Q2 2020, JP Morgan Chase held 5,976 positions worth $518B, up 22% from $426B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2020 filing shows 640 new, 2,055 increased, 2,340 reduced and 398 closed positions. Its largest new stake was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2020 buy was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2020, an estimated $2.63B increase.
- JP Morgan Chase's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.8B.
- JP Morgan Chase fully exited Allergan plc in Q2 2020, selling an estimated $656M.
- JP Morgan Chase's ten largest holdings make up 17% of its $518B portfolio in Q2 2020.
- JP Morgan Chase opened 640 new positions and closed 398 in Q2 2020.
- JP Morgan Chase's portfolio value rose 22% quarter-over-quarter to $518B.
Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.